Does China’s centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference…

Overview of attention for article published in Frontiers in Pharmacology, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,184 followers.

RT @FrontPharmacol: New Research: Does China's centralized Volume-Based Drug Procurement policy facilitate the transition from imitation to…

31 May 2023

Reply Repost Favourite

New Research: Does China's centralized Volume-Based Drug Procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model #pharmacology https://t.co/dXHfvStfAS

30 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.